A world-class specialty pharmaceutical company
Our ambition is to become a leading specialty pharmaceutical company meeting the needs of patients around the world. With our portfolio of respiratory products we’re making good progress towards achieving our goal.
- Proposed transfer of assets to and termination of agreement with AstraZeneca for consideration to be set off against debt and accrued interest
- Circassia Announces Business Update
- Update on Circassia’s Licensing Agreement with BeyondAir Inc. for LungFit PH